Vesta Therapeutics Overview

  • Founded
  • 2002
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Vesta Therapeutics General Information

Description

Developer of cell therapeutics technology intended to be used for liver repair and regeneration. The company's technology focuses on the isolation, expansion and cryopreservation of liver cells obtained from organ donor livers that are not suitable for whole organ transplantation, enabling patients with cirrhosis and end-stage liver disease and need a liver transplant, to get it done through a thorough research of Phase I clinical trial of cryopreserved, allogeneic human liver cells.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • 7513 Connelley Drive
  • Suite I
  • Hanover, MD 21076
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vesta Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jul-2019 Completed Out of Business
2. Grant 17-Jun-2005 Completed Startup
1. Early Stage VC Completed Startup
To view Vesta Therapeutics’s complete valuation and funding history, request access »